BioSpace News Archive

Today, ixlayer, a leader in technology-based solutions for healthcare management, announced a new platform to optimize and accelerate the highly-complex process of distributing COVID-19 vaccines while managing the response to the virus

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will be presenting at the Sidoti & Company Virtual Microcap Conference on Thursday, November 19, 2020 at 1:45 p.m. Eastern Time. The presentation will be webcast live and av

MOBILion Systems, Inc., a pioneer in fast, efficient, high-resolution instrumentation for biomarker discovery, diagnostics and therapeutic development, is collaborating with an international research team to identify alterations in the metabolism of selective glycosphingolipids in specific brain regions that contribute to the early onset and progression of Parkinson’s disease.

CSOFT International, a leading provider of cross-border multilingual localization and language technology solutions, is excited to announce that CSOFT Health Sciences Singapore has launched a wholly-owned subsidiary in Pingshan, Shenzhen.

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it ranked number 10 on Deloitte’s Technology Fast 500™ , a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tec

Northpond commits $12 million to create a Laboratory for Bioengineering Research and Innovation at the Wyss Institute for solutions-oriented research and development

Augmedix, a pioneer in the development of remote medical documentation, has been selected as a finalist for Red Herring’s Top 100 North America award, one of the technology industry’s most prestigious prizes.

The Medica EasyRA® benchtop clinical chemistry analyzer, distributed and serviced by Greensboro-based company, Carolina Liquid Chemistries Corp. (CLC), allows healthcare providers to test routine blood chemistries to include metabolic panels, liver enzymes, kidney function tests, glucose and cardiovascular tests.

Surgery Partners, Inc. announced that Wayne S. DeVeydt, Executive Chairman of the Board, Eric Evans, Chief Executive Officer and Tom Cowhey, Chief Financial Officer will participate in the 2nd Annual Wolfe Research Healthcare Conference on Thursday, November 19, 2020 at 9:00a.m..

The Broad Institute is expanding its Cancer Dependency Map Consortium, an academic-industrial partnership program that was first announced last year.